Grantham, Mayo, Van Otterloo & Co (GMO)
EW icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Edwards Lifesciences EW Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.78M Hold
20,664
– – ﹤0.01% 466
2026
Q2 		$1.87M Buy
20,664
+1,614
+8% +$135K ﹤0.01% 449
2026
Q1 		$1.53M Sell
19,050
-15,886
-45% -$1.31M ﹤0.01% 465
2025
Q4 		$2.98M Buy
34,936
+20,358
+140% +$1.67M 0.01% 375
2025
Q3 		$1.13M Buy
+14,578
New +$1.14M ﹤0.01% 468
2025
Q2 		– Sell
-26,591
Closed -$1.93M – 638
2025
Q1 		$1.93M Buy
+26,591
New +$1.9M 0.01% 381
2023
Q1 		– Sell
-3,000
Closed -$224K – 719
2022
Q4 		$224K Buy
+3,000
New +$231K ﹤0.01% 668
2022
Q2 		– Sell
-6,082
Closed -$716K – 770
2022
Q1 		$716K Buy
+6,082
New +$682K ﹤0.01% 561
2021
Q2 		– Sell
-33,763
Closed -$2.82M – 760
2021
Q1 		$2.82M Sell
33,763
-152,900
-82% -$12.9M 0.02% 422
2020
Q4 		$17M Buy
186,663
+179,064
+2,356% +$14.9M 0.1% 138
2020
Q3 		$607K Buy
+7,599
New +$593K ﹤0.01% 601
2016
Q2 		– Sell
-447,984
Closed -$13.2M – 581
2016
Q1 		$13.2M Sell
447,984
-197,370
-31% -$5.45M 0.05% 213
2015
Q4 		$17M Sell
645,354
-102,366
-14% -$2.66M 0.06% 162
2015
Q3 		$17.7M Sell
747,720
-14,694
-2% -$355K 0.06% 152
2015
Q2 		$18.1M Sell
762,414
-42,000
-5% -$948K 0.06% 143
2015
Q1 		$19.1M Buy
804,414
+39,600
+5% +$888K 0.06% 140
2014
Q4 		$16.2M Sell
764,814
-139,176
-15% -$2.8M 0.04% 156
2014
Q3 		$15.4M Sell
903,990
-100,686
-10% -$1.59M 0.04% 170
2014
Q2 		$14.4M Buy
1,004,676
+684,000
+213% +$9.27M 0.04% 174
2014
Q1 		$3.96M Sell
320,676
-87,246
-21% -$1.01M 0.01% 328
2013
Q4 		$4.47M Sell
407,922
-25,878
-6% -$292K 0.01% 330
2013
Q3 		$5.03M Buy
433,800
+97,200
+29% +$1.14M 0.01% 306
2013
Q2 		$3.77M Buy
+336,600
New +$3.98M 0.01% 341

Other funds holding EW

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s EW Position: Q3 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) held its Edwards Lifesciences (EW) position steady in Q3 2026 at 20,664 shares worth $1.78M. The position accounts for ﹤0.01% of the portfolio, ranked #466.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in EW in Q2 2013 and has held it in 23 quarters since. The position peaked at $19.1M in Q1 2015. 1,141 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 20,664 shares of Edwards Lifesciences worth $1.78M as of Q3 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) left its Edwards Lifesciences share count unchanged in Q3 2026.
  • Edwards Lifesciences made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q3 2026, its #466 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 23 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Edwards Lifesciences position peaked at $19.1M in Q1 2015.
  • 1,141 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2026, filed 13 Nov 2026.